Welcome to Yeast Infection Solution
.... a sure-fire, 100% guaranteed, clinically researched system that is backed by 25,000+ hours of nutritional expertise for eliminating yeast infection for good. This is a very rare, highly unique and potently powerful candida healing system, which very few people even know exists.......more
Updates on Vaginal Yeast Infection Treatment
Ask Dr. K: Many meds fight yeast infection - GoErie.com
Ask Dr. K: Many meds fight yeast infection GoErie.com Q I have a vaginal yeast infection. The itching and burning are unbearable. How should I treat it? And how did I get it in the first place? A Vaginal yeast infections are caused by a fungus that is usually present in small amounts on our skin, ... |
No Such Thing as a 'Normal' Vagina? - TIME
![]() TIME | No Such Thing as a 'Normal' Vagina? TIME It's the first study to document such dynamic differences, and could change the way doctors currently diagnose and treat vaginal infections. Yeast and bacterial infections affect about 25% to 30% of women in the US on any given day. |
5 Things You Should Reveal to Your OBGYN - Huffington Post (blog)
5 Things You Should Reveal to Your OBGYN Huffington Post (blog) If you feel itching or burning, or notice a difference in your discharge and think it may be a yeast infection, talk to your doctor to confirm diagnosis. You can easily treat a yeast infection with an over-the-counter like Monistat. |
Probiotic Remedies: 6 Ways Live Active Bacteria Can Boost Your Health - Huffington Post
Probiotic Remedies: 6 Ways Live Active Bacteria Can Boost Your Health Huffington Post Just like the digestive tract, the vagina relies on a precarious balance of good and bad bacteria. When that balance is off, it can result in one of two very common, though thoroughly uncomfortable infections: bacterial vaginosis and yeast infections. |
NovaDigm Therapeutics Presents Positive Safety and Immunogenicity Data in a ... - MarketWatch (press release)
NovaDigm Therapeutics Presents Positive Safety and Immunogenicity Data in a ... MarketWatch (press release) The demonstration of vaginal antibody responses to NDV-3 may be important in preventing vaginal yeast infections caused by Candida albicans, which is the objective of a planned Phase 2 efficacy study. The majority of subjects that received NDV-3 also ... |

